Interventional Cardiology Review最新文献

筛选
英文 中文
Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension. 肾去神经:健康专业人员管理高血压的实用指南。
Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.38
Roland Schmieder, Michel Burnier, Cara East, Konstantinos Tsioufis, Sean Delaney
{"title":"Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension.","authors":"Roland Schmieder,&nbsp;Michel Burnier,&nbsp;Cara East,&nbsp;Konstantinos Tsioufis,&nbsp;Sean Delaney","doi":"10.15420/icr.2022.38","DOIUrl":"https://doi.org/10.15420/icr.2022.38","url":null,"abstract":"<p><p>Growing evidence demonstrates the suitability of renal denervation in a broad population of patients; however, questions remain over its suitability and practical implementation. Given the rapidity of emerging data, this has been a challenging field for potential adopters to navigate. The purpose of this article is twofold: to provide navigation through emerging clinical data and evolving guidance; and to provide physicians with practical, evidence-based advice for identifying eligible patients and providing appropriate management in the pre- and postintervention settings. Although many of these recommendations are based on existing published guidance documents, we reflect equally on our own experiences of using this technology.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e06"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/42/35/icr-18-e06.PMC10433107.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10049172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis. Myval:一种治疗严重主动脉瓣狭窄的新型经导管心脏瓣膜。
Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2020.32
Ashok Seth, Vijay Kumar, Vivudh Pratap Singh, Dhananjay Kumar, Puneet Varma, Vishal Rastogi
{"title":"Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis.","authors":"Ashok Seth,&nbsp;Vijay Kumar,&nbsp;Vivudh Pratap Singh,&nbsp;Dhananjay Kumar,&nbsp;Puneet Varma,&nbsp;Vishal Rastogi","doi":"10.15420/icr.2020.32","DOIUrl":"https://doi.org/10.15420/icr.2020.32","url":null,"abstract":"<p><p>Transcatheter aortic valve implantation (TAVI) performed using femoral arterial access is now a guideline recommended treatment for severe calcific aortic stenosis (AS) in elderly patients. Technological advancements and procedural refinements have focused on making TAVI simpler, safer, more effective and durable. Myval (Meril Lifesciences) is a new generation balloon-expandable transcatheter heart valve (THV) developed in India that possesses novel features to improve deliverability and aid precise deployment. Following the first-in-human study, Myval was approved in India for commercial implantation in October 2018 and was subsequently given a CE mark in April 2019. This article reviews the science, technology and up-to-date clinical evidence for the Myval THV.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e12"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6c/87/icr-18-e12.PMC10311401.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9737632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence - Advisory or Adversary? 人工智能——顾问还是对手?
Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.22
Johny Nicolas, Nicholas L Pitaro, Birgit Vogel, Roxana Mehran
{"title":"Artificial Intelligence - Advisory or Adversary?","authors":"Johny Nicolas,&nbsp;Nicholas L Pitaro,&nbsp;Birgit Vogel,&nbsp;Roxana Mehran","doi":"10.15420/icr.2022.22","DOIUrl":"https://doi.org/10.15420/icr.2022.22","url":null,"abstract":"Artificial intelligence (AI) leverages computers and machines capable of performing high-level executive functions, mimicking human intelligence. Machine learning (ML) is a branch of AI capable of improving itself by learning from data, identifying patterns and making decisions without being explicitly programmed to do so. AI is already part of everyday life and used in areas including healthcare, banking systems and industry. In particular, AI has numerous applications in medicine, such as risk prediction, robotic surgery, automated imaging diagnosis and clinical research.1,2 Cardiology is at the forefront of the AI revolution, and there are many potential applications. Though concerns with AI credibility are more of an issue in healthcare than in other fields, the potential benefits of well-integrated AI tools for medicine in general and cardiology in particular are fascinating.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e17"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0a/3e/icr-18-e17.PMC10311397.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9743976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patent Foramen Ovale-associated Stroke and COVID-19 Vaccination. 卵圆孔未闭卒中与COVID-19疫苗接种。
Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2022.27
Maja Rojko, Natasa Cernic Suligoj, Metka Zorc, Marko Noc
{"title":"Patent Foramen Ovale-associated Stroke and COVID-19 Vaccination.","authors":"Maja Rojko,&nbsp;Natasa Cernic Suligoj,&nbsp;Metka Zorc,&nbsp;Marko Noc","doi":"10.15420/icr.2022.27","DOIUrl":"https://doi.org/10.15420/icr.2022.27","url":null,"abstract":"<p><p><b>Background:</b> COVID-19 infection has been associated with paradoxical thromboembolism through a patent foramen ovale (PFO) and ischaemic stroke. Such events have not been reported after COVID-19 vaccination. The aim of the present study was to investigate PFO-associated stroke during the mass COVID-19 vaccination in Slovenia. <b>Methods:</b> This prospective study, conducted between 26 December 2020 and 31 March 2022, enrolled consecutive patients (≥18 years) with PFO-associated stroke referred for a percutaneous closure to a single interventional facility in Slovenia. <b>Results:</b> A total of 953,546 people aged between 18 and 70 years received at least one dose of a COVID-19 vaccine approved by the European Medicines Agency. Of the 28 patients presenting with PFO-associated stroke, 12 patients (42.9%) were vaccinated prior to the event, of whom nine were women and three were men, aged between 21 and 70 years. Stroke occurred within 35 days after vaccination in six patients (50%). Clinical presentation included motor dysphasia, paresis, vertigo, ataxia, paraesthesia, headache, diplopia and hemianopia. At hospital discharge, 11 patients (91.6%) had at least one residual ischaemic lesion. <b>Conclusion:</b> A temporal coincidence of COVID-19 vaccination and PFO-associated stroke has been described. A potential cause-effect relationship may only be hypothesised.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e10"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5d/67/icr-18-e10.PMC10311394.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9746309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary Left Main Percutaneous Coronary Intervention: A State-of-the-art Review. 当代左主干经皮冠状动脉介入治疗:最新进展综述。
Interventional Cardiology Review Pub Date : 2023-01-01 DOI: 10.15420/icr.2023.02
Refai Showkathali, Radha Priya Yalamanchi
{"title":"Contemporary Left Main Percutaneous Coronary Intervention: A State-of-the-art Review.","authors":"Refai Showkathali,&nbsp;Radha Priya Yalamanchi","doi":"10.15420/icr.2023.02","DOIUrl":"https://doi.org/10.15420/icr.2023.02","url":null,"abstract":"<p><p>The majority of the left ventricular myocardium is supplied by the left main coronary artery. Atherosclerotic obstruction of the left main coronary artery therefore leads to significant myocardial jeopardy. Coronary artery bypass surgery (CABG) has been the gold standard for left main coronary artery disease in the past. However, advancements in technology have established percutaneous coronary intervention (PCI) as a standard, safe and reasonable alternative to CABG, with comparable outcomes. Contemporary PCI of left main coronary artery disease comprises careful patient selection, accurate technique guided by either intravascular ultrasound or optical coherence tomography and - if necessary - physiological assessment using fractional flow reserve. This review focuses on current evidence from registries and randomised trials comparing PCI with CABG, procedural tips and tricks, adjuvant technologies and the triumph of PCI.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"18 ","pages":"e20"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/11/icr-18-e20.PMC10331562.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9818462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
British Cardiovascular Interventional Society Consensus: a Huge Step Towards Standardised Care for Out-of-hospital Cardiac Arrest in the UK. 英国心血管介入学会共识:英国向院外心脏骤停标准化治疗迈出一大步。
IF 0.2
Interventional Cardiology Review Pub Date : 2022-11-10 eCollection Date: 2022-01-01 DOI: 10.15420/icr.2022.25
Marko Noc, Roxana Mehran
{"title":"British Cardiovascular Interventional Society Consensus: a Huge Step Towards Standardised Care for Out-of-hospital Cardiac Arrest in the UK.","authors":"Marko Noc, Roxana Mehran","doi":"10.15420/icr.2022.25","DOIUrl":"10.15420/icr.2022.25","url":null,"abstract":"","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"17 ","pages":"e17"},"PeriodicalIF":0.2,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/55/icr-17-e17.PMC9820175.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9099881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Coronary Intervention in Anomalous Right Coronary Artery: Ready to Implement in Clinical Routine? 异常右冠状动脉的经皮冠状动脉介入治疗:准备好在临床常规中实施了吗?
IF 0.2
Interventional Cardiology Review Pub Date : 2022-10-21 eCollection Date: 2022-01-01 DOI: 10.15420/icr.2022.17
Anselm W Stark, Christoph Gräni
{"title":"Percutaneous Coronary Intervention in Anomalous Right Coronary Artery: Ready to Implement in Clinical Routine?","authors":"Anselm W Stark, Christoph Gräni","doi":"10.15420/icr.2022.17","DOIUrl":"10.15420/icr.2022.17","url":null,"abstract":"","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"17 ","pages":"e15"},"PeriodicalIF":0.2,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/bc/icr-17-e15.PMC9819999.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9085611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excimer Laser Coronary Atherectomy to Treat Calcified Lesions. 准分子激光冠状动脉粥样硬化切除术治疗钙化病变。
Interventional Cardiology Review Pub Date : 2022-09-29 eCollection Date: 2022-01-01 DOI: 10.15420/icr.2022.10
Silvio Vera-Vera, Artemio Garcia, Santiago Jimenez-Valero, Guillermo Galeote, Raúl Moreno, Alfonso Jurado-Roman
{"title":"Excimer Laser Coronary Atherectomy to Treat Calcified Lesions.","authors":"Silvio Vera-Vera,&nbsp;Artemio Garcia,&nbsp;Santiago Jimenez-Valero,&nbsp;Guillermo Galeote,&nbsp;Raúl Moreno,&nbsp;Alfonso Jurado-Roman","doi":"10.15420/icr.2022.10","DOIUrl":"https://doi.org/10.15420/icr.2022.10","url":null,"abstract":"We fully agree with the authors on the benefits of intravascular lithotripsy (IVL), a technology that has changed the treatment of calcified lesions because of its safety and efficacy, as well as having potential advantages over other plaque modification techniques. Its main limitation is the crossing profile when treating a very tight and severely calcified stenosis where rotational (RA) or orbital atherectomy (OA) are very useful, as the authors describe.","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":" ","pages":"e14"},"PeriodicalIF":0.0,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/70/77/icr-17-e14.PMC9585644.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40454595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Transcatheter Aortic Valve Implantation for Severe Pure Aortic Regurgitation With Dedicated Devices. 使用专用装置经导管主动脉瓣植入术治疗重度纯主动脉反流。
Interventional Cardiology Review Pub Date : 2022-07-21 eCollection Date: 2022-01-01 DOI: 10.15420/icr.2021.19
Pierluigi Costanzo, Paul Bamborough, Mark Peterson, Djeven J Deva, Geraldine Ong, Neil Fam
{"title":"Transcatheter Aortic Valve Implantation for Severe Pure Aortic Regurgitation With Dedicated Devices.","authors":"Pierluigi Costanzo,&nbsp;Paul Bamborough,&nbsp;Mark Peterson,&nbsp;Djeven J Deva,&nbsp;Geraldine Ong,&nbsp;Neil Fam","doi":"10.15420/icr.2021.19","DOIUrl":"https://doi.org/10.15420/icr.2021.19","url":null,"abstract":"<p><p>Aortic regurgitation (AR) is not the most common valvular disease; however, its prevalence increases with age, with more than 2% of those aged >70 years having at least moderate AR. Once symptoms related to AR develop, the prognosis becomes poor. Transcatheter aortic valve implantation for patients with pure severe AR and at prohibitive surgical risk is occasionally performed, but remains a clinical challenge due to absence of valvular calcium, large aortic root and increased stroke volume. These issues make the positioning and deployment of transcatheter aortic valve implantation devices unpredictable, with a tendency to prosthesis embolisation or malposition. To date, the only two dedicated transcatheter valves for AR are the J-Valve (JC Medical) and the JenaValve (JenaValve Technology). Both devices have been used successfully via the transapical approach. The transfemoral experience is limited to first-in-human publications and to a clinical trial dedicated to AR, for which the completion date is still pending.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":" ","pages":"e11"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7b/6d/icr-17-e11.PMC9340575.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40669217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prognostic Value of Myocardial Blush Grade in ST-elevation MI: A Systematic Review and Meta-analysis. 心肌红肿分级对st段抬高型心肌梗死的预后价值:一项系统回顾和荟萃分析。
Interventional Cardiology Review Pub Date : 2022-07-21 eCollection Date: 2022-01-01 DOI: 10.15420/icr.2022.01
Patrick Vera Cruz, Patricio Palmes, Nadine Bacalangco
{"title":"Prognostic Value of Myocardial Blush Grade in ST-elevation MI: A Systematic Review and Meta-analysis.","authors":"Patrick Vera Cruz,&nbsp;Patricio Palmes,&nbsp;Nadine Bacalangco","doi":"10.15420/icr.2022.01","DOIUrl":"https://doi.org/10.15420/icr.2022.01","url":null,"abstract":"<p><p><b>Background:</b> Ineffective myocardial perfusion despite angiographic success after angioplasty occurs frequently and is associated with an increased risk of mortality. Hence, this study determined whether myocardial perfusion measured by myocardial blush grade (MBG) identifies ST-elevation MI (STEMI) patients at high risk for poor outcomes after successful angioplasty. <b>Methods:</b> The search employed strategies designed for research databases. An article was eligible if it included adults who underwent coronary angioplasty for STEMI, post-angioplasty MBG was assessed, and mortality or major adverse cardiovascular events (MACE) were determined. Risk for bias was assessed using the Quality In Prognosis Studies tool and forest plots in a Mantel-Haenszel fixed effects model were created using RevMan5.4. <b>Results/discussion:</b> Eight observational studies with an overall low risk of bias were included, involving 8,044 patients. MBG 0/1 with no to poor myocardial perfusion had a negative prognostic value for mortality (OR 2.68; 95% CI [2.22-3.23]) and MACE (OR 1.20; 95% CI [1.01-1.41]). Furthermore, MBG 2 with moderate myocardial perfusion and MBG 3 with normal myocardial perfusion were associated with increased survival with a logHR of 0.47 (95% CI [0.43-0.52]) and 0.20 percutaneous coronary intervention (95% CI [0.18-0.23]). These results imply MBG is a useful prognostic marker for STEMI patients. <b>Conclusion:</b> MBG 0/1 after primary angioplasty is a strong negative prognostic marker for long-term all-cause mortality and MACE among STEMI patients, and a post-primary angioplasty MBG of 2 or 3 is a robust prognostic marker for long-term survival.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":" ","pages":"e10"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/71/65/icr-17-e10.PMC9340576.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40669215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信